Combined effects of caffeine and prostaglandin E2 on the proliferation of osteoblast-like cells (UMR106-01)

Journal of Periodontology

Volumn 70, Issue 3, 1999, Pages 283-288

  Kamagata Kiyoura, Yusuke ^b   Ohta, Mitsuhiro ^b   Cheuk, Gina ^b   Yazdani, Malektaj ^b   Saltzman, Marty J ^b   Nakamoto, Tetsuo ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b NONE

Author keywords

Caffeine adverse effects; Dinoprostone adverse effects; Indomethacin adverse effects; Periodontitis pathogenesis; Risk factors

Indexed keywords

CAFFEINE; INDOMETACIN; PROSTAGLANDIN E2;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; BONE METABOLISM; CELL PROLIFERATION; DRUG EFFECT; GROWTH INHIBITION; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PERIODONTAL DISEASE; PERIODONTITIS; PROSTAGLANDIN SYNTHESIS; RAT;

1-METHYL-3-ISOBUTYLXANTHINE; ANIMALS; CAFFEINE; CELL DIVISION; CELL LINE; CYCLIC AMP; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FORSKOLIN; INDOMETHACIN; OSTEOBLASTS; PERIODONTITIS; PHOSPHODIESTERASE INHIBITORS; RATS; RISK FACTORS; TIME FACTORS;

EID: 0032929521     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1999.70.3.283     Document Type: Article

References (31)

1. Kiel DP, Felson DT, Hannan MT, Anderson JJ, Wilson PWF. Caffeine and the risk of hip fracture: The Framingham Study. Am J Epidemiol 1990;132:675-684.
2. Lloyd T, Rollings N, Eggli DF, Kieselhorst K, Chinchilli VM. Dietary caffeine intake and bone status of postmenopausal women. Am J Clin Nutr 1997;65:1826-1830.
3. Barone JJ, Grice HC. Seventh International Caffeine Workshop. Food Chem Toxicol 1994;32:65-77.
4. Kamagata-Kiyoura Y, Ohta M, Yazdani M, Nakamoto T. Effect of caffeine on osteoblast-like cells in vitro. J Dent Res 1997;76:236 (Abstr. 1778).
5. Wink CS, Rossowska MJ, Nakamoto T. Effects of caffeine on bone cells and bone development in fast-growing rats. Anat Rec 1996;246:30-38.
6. 2, and immunoglobulin G subclasses in gingival crevicular fluid in patients undergoing periodontal therapy. J Periodontol 1996;67:755-762.
7. Dongari-Bagtzoglou AI, Ebersole JL. Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge. J Periodont Res 1996;31:90-98.
8. 2 levels as a predictor of periodontal attachment loss. J Periodont Res 1986;21:101-112.
9. 2 stimulates DNA synthesis by a cyclic AMP-independent pathway in osteoblastic clone MC3T3-E1 cells. J Cell Physiol 1986;128:155-161.
10. 2 in organ culture. Prostaglandins 1974;8:377-385.
11. Drake MT, Baldassare JJ, McConke CL, Gonzalez EA, Martin KJ. Parathyroid hormone increases the expression of receptors of epidermal growth factor in UMR106-01 cells. Endocrinol 1994;134:1733-1737.
12. Ethier MF, Chander V, Dobson JG. Adenosine stimulates proliferation of human endothelial cells in culture. Am J Physiol 1993;265:H131-H138.
13. Morandini R, Ghanem G, Portier-Lemarie A, Robaye B, Renaud A, Boeynaems JM. Action of cAMP on expression and release of adhesion molecules in human endothelial cells. Am J Physiol 1996;270:H807-H816.
14. Heaney RP, Recker RR. Effect of nitrogen, phosphorus and caffeine on calcium balance in women. J Lab Clin Med 1982;99:46-55.
15. Stein GS, Lian JB, Stein JL, VanWijnen AJ, Montecino M. Transcriptional control of osteoblast growth and differentiation. Physiol Rev 1996;76:593-629.
16. Feyen JHM, DiBon A, Vanderplas A, Lowik CWGM, Nijweide PJ. Effect of exogenous prostanoids on the proliferation of osteoblast-like cells in vitro. Prostaglandins 1985;30:827-840.
17. Harper RA. Effects of prostaglandins on 3H-thymidine uptake into human epidermal cells in vitro. Prostaglandins 1976;12:1019-1025.
18. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-444.
19. 2 and IL-1ß release by LPS-treated human monocytes. J Periodont Res 1996;31:99-104.
20. Wahl LM, Lampel LL Regulation of human peripheral blood collagenase by prostaglandins and anti-inflammatory drugs. Cell Immunol 1987;105:411-422.
21. Klein DC, Raisz LG. Prostaglandin stimulation of bone resorption in tissue culture. Endocrinol 1970;86:1436-1440.
22. 2 levels as a measure of the periodontal disease status of adult and juvenile periodontitis patients. J Periodont Res 1984;19:1-13.
23. Kaplan GB, Greenblatt DJ, Ehrenberg BL, et al. Dosedependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol 1997;37:693-703.
24. Naderal EK, Poyser NL. Effects of caffeine and theophylline on prostaglandin production by guinea-pig endometrium. Prostaglandins Leukoc Med 1997;56:63-67.
25. Whitney SJ. Effect of prostaglandin inhibition on caffeine-induced hypercalciuria in healthy women. J Nutr Biochem 1990;1:201-205.
26. 2. Ann Anat 1996;178:229-236.
27. Fredholm BB. On the mechanism of action of theophylline and caffeine. Acta Med Scand 1985;217:149-153.
28. Huttner A, Lei T, Fahlbusch R, Schrell U, Adams El. Relationship between cAMP induced inhibition of human meningioma cell proliferation and autocrine secretion of interleukin-6. Life Sci 1996;58:1323-1329.
29. Mellgren G, Vintermyr OK, Døskeland SO. Okadaic acid, cAMP, and selected nutrients inhibit hepatocyte proliferation at different stages in G1: Modulation of cAMP effect by phosphatase inhibitors and nutrients. J Cell Physiol 1995;163:232-240.
30. Hakeda Y, Nakatani Y, Hiramatsu M, et al. Inductive effect of prostaglandins on alkaline phosphatase in osteoblastic cells, clone, MC3T3-E1. J Biochem 1985;97:97-104.
31. Genco RJ. Current view of risk factors for periodontal diseases. J Periodontol 1996;67(suppl.):1041-1049.